All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • XaluritamigAMG 509Phase 32 trials

    Amgen · Metastatic Castration-resistant Prostate Cancer

  • XNW28012Phase 32 trials

    Evopoint Biosciences Inc. · Pancreatic Cancer, Advanced Solid Tumors, Pancreatic Carcinoma

  • XZP-3287Phase 32 trials

    Xuanzhu Biopharmaceutical Co., Ltd. · Advanced Breast Cancer

  • YJ001Phase 32 trials

    Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · Diabetic Peripheral Neuropathic Pain (DPNP)

  • zeleciment basivarsenDYNE-101Phase 32 trials

    Dyne Therapeutics · Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy

  • Zeleciment RostudirsenDYNE-251Phase 32 trials

    Dyne Therapeutics · Duchenne Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne, Muscular Dystrophy (DMD)

  • zelicapavirPhase 32 trials

    Enanta Pharmaceuticals, Inc · RSV, RSV Infection, Respiratory Syncytial Virus (RSV)

  • ZimislecelFormerly known as STx-02, VX-880Phase 32 trials

    Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1

  • ZiresovirAK0529Phase 32 trials

    Shanghai Ark Biopharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections, Respiratory Synctial Virus Infections

  • ZN-A-1041ZN-A-1041 Enteric, RO7771950Phase 32 trials

    Roche (Genentech) · HER2-positive Breast Cancer, Advanced Solid Tumors

  • zorevunersenSTK-001Phase 32 trials

    Stoke Therapeutics, Inc · Dravet Syndrome

  • ZSP1273Phase 32 trials

    Guangdong Raynovent Biotech Co., Ltd · Influenza A, Influenza a

  • ZuberitamabPhase 32 trials

    BioRay Pharmaceutical Co., Ltd. · Primary Membranous Nephropathy

  • ABBV-1480Phase 31 trial

    AbbVie · Non-Small Cell Lung Cancer

  • ABBV-444Phase 31 trial

    AbbVie · Dry Eye Disease

  • ABP 692Phase 31 trial

    Amgen · Relapsing-remitting Multiple Sclerosis (RRMS)

  • ABP 938Phase 31 trial

    Amgen · Neovascular Age-related Macular Degeneration, nAMD

  • AcasunlimabGEN1046, DuoBody-PD-L1×4-1BBPhase 31 trial

    Genmab · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

  • AD-218Phase 31 trial

    Addpharma Inc. · Mixed Dyslipidemia

  • AD-218APhase 31 trial

    Addpharma Inc. · Mixed Dyslipidemia

  • AD-223APhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-223BPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-223CPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224APhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224BPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224CPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-227APhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-227BPhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-227CPhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-2281Phase 31 trial

    Addpharma Inc. · Primary Hypercholesterolemia

  • AD-2282Phase 31 trial

    Addpharma Inc. · Primary Hypercholesterolemia

  • AD-233APhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233BPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233CPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233DPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • ADC189Phase 31 trial

    Jiaxing AnDiCon Biotech Co.,Ltd · Influenza Type A, Influenza Type B

  • adebelizumabPhase 31 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced or Metastatic Non-small Cell Lung Cancer

  • ADX-2191Phase 31 trial

    Aldeyra Therapeutics, Inc. · Primary Vitreoretinal Lymphoma

  • AG-236Phase 31 trial

    Agios Pharmaceuticals, Inc. · Polycythemia Vera

  • AG2001Phase 31 trial

    Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis

  • AG20011Phase 31 trial

    Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis

  • AG20012Phase 31 trial

    Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis

  • AG2304RPhase 31 trial

    Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia

  • AG2304TPhase 31 trial

    Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia

  • AK105Phase 31 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)

  • AK3280Phase 31 trial

    Shanghai Ark Biopharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)

  • Jiangsu Healthy Life Innovation Medical Technology Co., Ltd · Locally Advanced Pancreatic Cancer

  • Alflutinib MesylatePhase 31 trial

    Allist Pharmaceuticals, Inc. · Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer

  • AnaprazolePhase 31 trial

    Xuanzhu Biopharmaceutical Co., Ltd. · Reflux Esophagitis (RE)

  • APC101Phase 31 trial

    Andros Pharmaceuticals Co., Ltd. · PHN - Post-Herpetic Neuritis

NewerPage 20 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.